Unknown

Dataset Information

0

Targeting foam cell formation in inflammatory brain diseases by the histone modifier MS-275.


ABSTRACT: OBJECTIVE:To assess class I-histone deacetylase (HDAC) inhibition on formation of lipid-accumulating, disease-promoting phagocytes upon myelin load in vitro, relevant for neuroinflammatory disorders like multiple sclerosis (MS) and cerebral X-linked adrenoleukodystrophy (X-ALD). METHODS:Immunohistochemistry on postmortem brain tissue of acute MS (n = 6) and cerebral ALD (n = 4) cases to analyze activation and foam cell state of phagocytes. RNA-Seq of in vitro differentiated healthy macrophages (n = 8) after sustained myelin-loading to assess the metabolic shift associated with foam cell formation. RNA-Seq analysis of genes linked to lipid degradation and export in MS-275-treated human HAP1 cells and RT-qPCR analysis of HAP1 cells knocked out for individual members of class I HDACs or the corresponding enzymatically inactive knock-in mutants. Investigation of intracellular lipid/myelin content after MS-275 treatment of myelin-laden human foam cells. Analysis of disease characteristic very long-chain fatty acid (VLCFA) metabolism and inflammatory state in MS-275-treated X-ALD macrophages. RESULTS:Enlarged foam cells coincided with a pro-inflammatory, lesion-promoting phenotype in postmortem tissue of MS and cerebral ALD patients. Healthy in vitro myelin laden foam cells upregulated genes linked to LXR?/PPAR? pathways and mimicked a program associated with tissue repair. Treating these cells with MS-275, amplified this gene transcription program and significantly reduced lipid and cholesterol accumulation and, thus, foam cell formation. In macrophages derived from X-ALD patients, MS-275 improved the disease-associated alterations of VLCFA metabolism and reduced the pro-inflammatory status of these cells. INTERPRETATION:These findings identify class I-HDAC inhibition as a potential novel strategy to prevent disease promoting foam cell formation in CNS inflammation.

SUBMITTER: Zierfuss B 

PROVIDER: S-EPMC7664285 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeting foam cell formation in inflammatory brain diseases by the histone modifier MS-275.

Zierfuss Bettina B   Weinhofer Isabelle I   Buda Agnieszka A   Popitsch Niko N   Hess Lena L   Moos Verena V   Hametner Simon S   Kemp Stephan S   Köhler Wolfgang W   Forss-Petter Sonja S   Seiser Christian C   Berger Johannes J  

Annals of clinical and translational neurology 20200930 11


<h4>Objective</h4>To assess class I-histone deacetylase (HDAC) inhibition on formation of lipid-accumulating, disease-promoting phagocytes upon myelin load in vitro, relevant for neuroinflammatory disorders like multiple sclerosis (MS) and cerebral X-linked adrenoleukodystrophy (X-ALD).<h4>Methods</h4>Immunohistochemistry on postmortem brain tissue of acute MS (n = 6) and cerebral ALD (n = 4) cases to analyze activation and foam cell state of phagocytes. RNA-Seq of in vitro differentiated health  ...[more]

Similar Datasets

| S-EPMC2908422 | biostudies-other
| S-EPMC9749924 | biostudies-literature
| S-EPMC6398866 | biostudies-literature
| S-EPMC4294305 | biostudies-literature
2015-05-16 | E-GEOD-68959 | biostudies-arrayexpress
2015-05-16 | GSE68959 | GEO
2020-09-23 | GSE138495 | GEO
| S-EPMC3190994 | biostudies-literature
| S-EPMC4492558 | biostudies-literature
| S-EPMC10706318 | biostudies-literature